tradmap

NUTX Earnings Nutex Health Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$100 -$45 $10 $0 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $438M $875M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$425M -$146M $133M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$7 $2 $11 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $134M $268M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$32M $17M $66M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–26 of 26
Q2 20262026-06-309.382026-08-0610-Q
Q1 20262026-03-316.522026-04-3010-Q
Q4 2025 (derived)2025-12-312.342026-03-0510-K
FY 20252025-12-3110.482026-03-0510-K
Q3 20252025-09-307.762025-11-1910-Q
Q2 20252025-06-30-2.952025-11-1810-Q
Q1 20252025-03-313.332025-05-1310-Q
Q4 20242024-12-3111.122025-03-3110-K
FY 20242024-12-319.692025-03-3110-K
Q3 20242024-09-30-1.722024-11-0710-Q
Q2 20242024-06-30-0.072024-08-0810-Q
Q1 20242024-03-31-0.112024-05-0910-Q
Q4 20232023-12-31-7.472024-03-2910-K
FY 20232023-12-31-10.392024-03-2910-K
Q3 20232023-09-30-1.252023-11-0910-Q
Q2 20232023-06-30-0.792023-08-0910-Q
Q1 20232023-03-31-1.202023-05-1510-Q
Q4 20222022-12-31-0.022023-03-0310-K
FY 20222022-12-31-100.362023-03-0310-K
Q3 20222022-09-30-0.622022-11-2110-Q
Q2 20222022-06-30-0.032022-08-2210-Q
Q1 20222022-03-310.04——
FY 20212021-12-310.22——
Q3 20212021-09-300.09——
Q2 20212021-06-300.05——
FY 20202020-12-310.18——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.